F. Barlesi

Discipline

Economies et finances (2) Sociologie (1) Psychologie (1) Sciences de l'information et de la communication (1)

Type de document

Articles (12) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Patients (10) Cancer (9) Patients (9) Cancer (9) cancer (8) Oncology (8) oncologie (7) mortalité (6) Mortality (6) Mortality (6) Human beings (6) Impact (6) risque (5) âge (5) Treatment (5) Risk (5) Pneumonia (5) Age (5) Age (5) maladie (5) modèle (4) maladie (4) Development (4) Theater (4) Lungs--Cancer (4) Lungs (4) Example (4) Drama (4) Acting (4) thérapie (3)

Documents écrit par F. Barlesi (12) | parle de F. Barlesi (0)

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
M.F. Mosele et al. (27 mai 2024)
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
E. Charton et al.
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.
O. Wysocki et al. (16 août 2022)
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.
J.G. Whisenant et al.
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.
R.J. Lee et al.
OncoAlert Round Table Discussions: The Global COVID-19 Experience.
G. Morgan et al.
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
A. Trama et al. (9 nov. 2020)
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
M.C. Garassino et al.
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
J.G. Whisenant et al. (8 juin 2020)
Challenges in lung cancer therapy during the COVID-19 pandemic.
L. Calabrò et al.
Oncogenic drivers in daily practice improve overall survival in patients ă with lung adenocarcinoma
Clarisse Fournier et al. (nov. 2016)
Qualité de vie : attitudes et perceptions des médecins d'un réseau régional de soins en oncologie thoracique
F. Barlési et al. (2006)